Indications, prognosis, and complications of de Novo implantable cardioverter defibrillators in patients with and without type 2 diabetes: a nationwide registry-based cohort study
Patients with type 2 diabetes more often received ICDs for PP and ischemic indications than No-DM patients and had a worse prognosis despite similar one-year infection risk. This likely reflects greater comorbidity burden and diabetes-specific factors, indicating the need for tailored risk management strategies beyond device implantation in patients with type 2 diabetes.
Authors
- Soffia Guðbjörnsdóttir (ORCID: https://orcid.org/0000-0002-6583-5581)
- Per Näsman (ORCID: https://orcid.org/0000-0001-7606-8771)
- Tigist Wodaje
- Y. P. Zhou
- Linda Mellbin (ORCID: https://orcid.org/0000-0001-8655-4044)
- Fredrik Gadler (ORCID: https://orcid.org/0000-0002-1027-9434)
- Elina Rautio (ORCID: https://orcid.org/0000-0002-9846-2128)
- Lina Rydén (ORCID: https://orcid.org/0000-0002-3817-2620)
Institutions
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- KTH Royal Institute of Technology (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Cardiovascular Diabetology
- Published
- 2025-12-31
- DOI
- https://doi.org/10.1186/s12933-025-03044-5
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00